Permanently Discontinued

AMARYL

SANOFI-AVENTIS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is AMARYL discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that AMARYL 2MG has been permanently discontinued (last updated September 7, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is AMARYL not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file5 products

Affected strength2MG

Last updated2018-09-07

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

NOVO-GLIMEPIRIDE

NOVOPHARM LIMITED

2MG · DIN 02273764

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

PMS-GLIMEPIRIDE

PHARMASCIENCE INC

2MG · DIN 02284553

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

SANDOZ GLIMEPIRIDE

SANDOZ CANADA INCORPORATED

3MG · DIN 02269600

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

RATIO-GLIMEPIRIDE

TEVA CANADA LIMITED

1MG · DIN 02273101

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

CO GLIMEPIRIDE

COBALT PHARMACEUTICALS COMPANY

4MG · DIN 02274272

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02245273

Strength

2MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

GLIMEPIRIDE

Tier

Unrated

Last Updated

2018-09-07

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from SANOFI-AVENTIS CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

DIN 02464349

10MCG · DIN 02464276

20MCG · DIN 02464284

100UNIT · DIN 02469901

ADMELOG

100UNIT · DIN 02469898

ADMELOG SOLOSTAR

100UNIT · DIN 02469871